We gave Grok a longevity team 🧬
PLSI helps turn your health data into a plan and puts spare AI usage to work on aging research.
Your AI can help you stay healthier AND contribute to science.
We built it at Insilico. Now it’s your turn to try it out👇
https://t.co/OrKiANe8U2
#Longevity #Grok #GrokBot #CitizenScience
🌍 The complete longevity ecosystem, with citizen scientists, longevity medicine doctors, and institutional researchers working together around the clock with frontier AI systems, has long been a personal dream.
🧬 Its goal is to extend and improve life for everyone on the planet in a sustainable, maximally beneficial way, with full individual control. Grok Bot (@bot) made this possible.
🚀 When infrastructure and intelligence from the planet’s strongest technology and engineering team, with rigorous data security, privacy, and real flexibility, meet the strongest longevity AI research teams, always-on longevity superintelligence becomes reality.
Set up your own Longevity Grok: https://t.co/3gv4Q8E2yn
Insilico Medicine 🤝 @davidasinclair
4 state-of-the-art drug discovery models. FREE to try. 🧪
Got compounds? Put them to the test.
💊 ADMET. Kinase selectivity. GPCR interactions. Synthetic chemistry.
Your compounds. Real-time predictions. Zero cost to try.
👉 https://t.co/8puf2kwEFV
Thought pharma was too complex for Jev-like models? Don't think twice.
A plain-language guide to System 1 in drug discovery: what Jev actually does, why new molecules are the hard part, and how small language models answer, fast and accurately, today. https://t.co/pf1jb91Ocp
1.5 years ago, we bet the company on benchmarking and evaluating all things AI for science.
Today, we’re #1 in many areas. One of them is AI for longevity. Just ask your favorite LLM.
Here’s what GPT Astra says about our Cell cover paper 👇
Link in the comments
Can you checkmate Aging before time beats you?
@elonmusk and @chesscom debated whether computers could solve chess.
10 minutes. Research tools for pieces. Biology makes the counter-moves.
Your move: https://t.co/8FUNBFT9cS 👇
The inspiration: @InSilicoMeds’ MMAI Gym trains AI for drug discovery and longevity.
AgeMate turns that idea into a chess metaphor: every move is a hypothesis, every reply a biological challenge.
The real endgame is longer, healthier lives.
Aging has a language. 🧬 We’re teaching AI to read it.
On the cover of Cell: compact Longevity-LLMs, jointly trained by Insilico Medicine and @liquidai, demonstrate SOTA performance on LongevityBench.
Powered by these models, Longevity Claw nominated 328 candidate gene targets for aging research.
Small model. Big questions. Open source. 🧵👇
#insilicoSOTAFM
🇦🇪 New AI drug discovery milestone from the UAE: BTK-targeting PROTACs for potential applications in blood cancers.
Our UAE team used AI to help design a new series of BTK degraders.
🧬 Lead compounds showed picomolar BTK degradation
💊 Oral bioavailability in mice
🎯 Activity against wild-type and mutated BTK
🤖 Novel building blocks designed with Chemistry42
The research was published in the Journal of Medicinal Chemistry and builds on Insilico Medicine’s growing drug discovery efforts in the UAE.
From designing molecules locally to publishing internationally, this is another step toward building AI-powered drug discovery capabilities in Abu Dhabi. 🇦🇪
I challenge you to defeat Aging! ⏳ 🛹
Start as a base model. Collect data from our MMAI GYM, use #AgenticPharma, and evolve into PharmaAGI. 🧬 ⚡
15 domains. One run. Can you become #insilicoSOTAFM?
Scientific papers are still surprisingly static.
Sometimes a 30-second animation can communicate a mechanism more clearly than several pages of figures and captions.
Why isn't video a more standard part of scientific publishing?
Paper: https://t.co/SQ4OAIefUu
@AlecTPhD
The LLM race is getting interesting in a different way: not just smarter models, but better tools.
GPT-6 Astra keeps surprising me with what one prompt can produce.
Here's @InSilicoMeds' ChemCensor assessing reactions against real synthetic precedents.
@OpenAI@joyjiao12